Peadar O'Gaora

Title: Peadar O'Gaora: Innovator in Cancer Assessment

Introduction

Peadar O'Gaora is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of cancer research, particularly in the assessment of breast cancer recurrence. His innovative methods have the potential to improve patient outcomes and provide valuable insights into cancer prognosis.

Latest Patents

O'Gaora holds a patent for a "Method of assessing cancer status in a breast cancer patient." This patent describes methods for assessing recurrence status in breast cancer patients by analyzing biological samples for specific biomarkers, such as S100β or HOX-C1I. Positive detection of these biomarkers indicates a higher likelihood of cancer recurrence. The method can also be utilized for diagnosing recurrence in patients undergoing first-line therapy or those who have had surgery to remove a primary breast tumor. O'Gaora's patent represents a significant advancement in the prognosis of poor disease-free survival in breast cancer patients.

Career Highlights

Throughout his career, O'Gaora has worked with prestigious institutions, including University College Dublin and the Royal College of Surgeons in Ireland. His work has focused on developing innovative methods for cancer assessment, contributing to the scientific community's understanding of breast cancer recurrence.

Collaborations

O'Gaora has collaborated with notable colleagues, including Leonie Young and Marie McIlroy. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer assessment.

Conclusion

Peadar O'Gaora's contributions to cancer research, particularly through his patented methods for assessing breast cancer recurrence, highlight his commitment to improving patient care. His work continues to influence the field and offers hope for better prognostic tools in oncology.